For example, SHBG levels are negatively correlated with markers of hepatic de novo lipogenesis (DNL), indicating that enhanced lipogenesis contributes to reduced SHBG synthesis and release, especially in individuals with obesity and hepatic steatosis. Here, SHBG is linked to fatty liver disease.